Praxis Precision Medicines, Inc. (PRAX)
248.24
+9.22
(+3.86%)
USD |
NASDAQ |
Oct 15, 16:00
254.56
+6.32
(+2.55%)
After-Hours: 20:00
Praxis Precision Medicines Cash from Operations (TTM) : -305.24M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -305.24M |
| March 31, 2026 | -282.41M |
| December 31, 2025 | -249.07M |
| September 30, 2025 | -228.77M |
| June 30, 2025 | -191.24M |
| March 31, 2025 | -163.88M |
| December 31, 2024 | -131.76M |
| September 30, 2024 | -98.40M |
| June 30, 2024 | -94.15M |
| March 31, 2024 | -98.11M |
| December 31, 2023 | -110.13M |
| September 30, 2023 | -115.10M |
| Date | Value |
|---|---|
| June 30, 2023 | -136.84M |
| March 31, 2023 | -162.76M |
| December 31, 2022 | -184.23M |
| September 30, 2022 | -200.32M |
| June 30, 2022 | -179.40M |
| March 31, 2022 | -152.34M |
| December 31, 2021 | -123.79M |
| September 30, 2021 | -99.18M |
| June 30, 2021 | -89.12M |
| March 31, 2021 | -69.06M |
| December 31, 2020 | -51.93M |
| September 30, 2020 | -41.67M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 857.09M |
| Insmed, Inc. | -778.92M |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Xencor, Inc. | -205.81M |